Bulletin from the Annual General Meeting of ExpreS2ion Biotech Holding AB held on 5 June 2024
The Annual General Meeting 2024 (the "AGM") of ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") was held today on 5 June 2024.Adoption of the income statement and the balance sheet The AGM resolved to adopt the income statement and balance sheet and the group income statement and group balance sheet as presented in the annual report for the financial year 2023. Allocation of profit The AGM resolved, in accordance with the board's proposal, that all funds available to the AGM shall be carried forward. Discharge from liability The Board of Directors and the CEO